This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Clarence H. Hale
Introduction
Clarence H. Hale is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of cardiometabolic syndrome. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Hale holds a patent titled "Use of GDF15 for Treating Cardiometabolic Syndrome and Other Conditions." This patent represents a breakthrough in understanding how GDF15 can be utilized to improve health outcomes for individuals suffering from various conditions related to cardiometabolic syndrome. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Clarence H. Hale is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to healthcare. His work at Amgen has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to medical research.
Collaborations
Hale has worked alongside talented colleagues such as Xin Luo and Murielle Marie V. Ellison. These collaborations have played a crucial role in the development of his patent and have fostered a productive environment for innovation.
Conclusion
Clarence H. Hale's contributions to the field of medicine through his patent on GDF15 highlight his dedication to improving health outcomes. His work at Amgen and collaborations with esteemed colleagues further emphasize his impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile